Insulet climbs after quarterly results beat
** Shares of medical device maker Insulet PODD.O rise 4.5% to $161.44 in morning trading
** Company reports Q3 adj. profit of $1.99 per share versus analysts' average estimate of $1.59 per share, according to data compiled by LSEG
** PODD's quarterly revenue of $842 million beats analysts' average expectation of $832.69 million
** Company says Q3 sales from its Omnipod insulin pumps rose 19.7% to $836.6 million
** Including session's move, stock down 43% YTD